‐19 continues to significantly impact the United States from a physical, mental and financial standpoint, an early analysis by a pharmacy benefit management organization of filled prescriptions at the onset of COVID‐19 has found increases in the use of anti‐anxiety and antidepressant medications....
No medications are currently approved in the United States for stress incontinence. Instead, women are encouraged to perform exercises to strengthen their pelvic floor, and in chronic cases to undergosurgery. For this study, 231 women with stress incontinence being treated at 25 clinics in Japan we...
Prescription medications often can interact with many popular OTC medicines, and, because many employees never inform supervisors of prescriptions they are taking, the safety of medicated workers and those around them can be a concern.Prescriptions for anxiety and depression are one of the fastest-...
In contrast to most fields of medicine, progress to discover and develop new and improved psychiatric drugs has been slow and disappointing. The vast majority of currently prescribed drugs to treat schizophrenia, mood and anxiety disorders are arguably n
Recent studies have clearly demonstrated the efficacy of selective serotonin reuptake inhibitors in young people with obsessive-compulsive disorder and mixed or generalized anxiety disorders. Evidence is emerging for effectiveness in social phobia and its variant, selective mutism. Since the effect size ...
202 www.neuropsychopharmacology.org REVIEW Biomarkers for the Development of New Medications for Cocaine Dependence Kristopher J Bough1, Shashi Amur2, Guifang Lao3, Scott E Hemby4, Nilesh S Tannu5, Kyle M Kampman6, Joy M Schmitz7, Diana Martinez8, Kalpana M Merchant9, Charles Green10, ...
"We have used amedicationthat blocks the way the body breaks down its own cannabis-like substances, or 'endocannabinoids." Our study shows that this class of medications, called FAAH inhibitors, may offer a new way to treat PTSD and perhaps also other stress-related psychiatric conditions. The...
These medications are well-tolerated, but motor and behavioral side effects are more common in young people. Long-term research and postmarketing surveillance are needed.doi:10.1586/14737175.2.2.203GarlandE JaneExpert Rev NeurotherExpert Review of Neurotherapeutics...
American biopharmaceutical research companies are currently developing almost 36 new medications for schizophrenia, and a total of 119 new medicines targeting
National Institute for Health and Care Excellence. Bipolar disorder: the assessment and management of bipolar disorder (2023 updated edition). 2014. https://www.nice.org.uk/. Accessed 22 Dec 2023. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CA...